{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:59:25Z","timestamp":1792511965614,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006279","name":"Abbott Cardiovascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jcin.2025.01.440","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:51:32Z","timestamp":1745423492000},"page":"1217-1228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Relationships of hsCRP to High-Risk Vulnerable Plaque After NSTEMI"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5846-345X","authenticated-orcid":false,"given":"Ole","family":"Fr\u00f6bert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alf Inge","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lak N.","family":"Kotinkaduwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Engstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kj\u00f8ller-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2082-0247","authenticated-orcid":false,"given":"Mitsuaki","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Ben-Yehuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Erik","family":"B\u00f8tker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Wiseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-2429","authenticated-orcid":false,"given":"Lisette O.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan E.","family":"Nordrehaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Trovik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Bleie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmir","family":"Omerovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Erlinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2025.01.440_bib1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2025.01.440_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.atherosclerosis.2020.03.022","article-title":"The relation between healthy lifestyle changes and decrease in systemic inflammation in patients with stable cardiovascular disease","volume":"301","author":"van 't Klooster","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jcin.2025.01.440_bib3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2025.01.440_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2025.01.440_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"Nissen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2025.01.440_bib6","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.amjcard.2014.08.013","article-title":"Relation of C-reactive protein to coronary plaque characteristics on grayscale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris (from the ATHEROREMO-IVUS study)","volume":"114","author":"Cheng","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2025.01.440_bib7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(21)00249-X","article-title":"Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II):a prospective natural history study","volume":"397","author":"Erlinge","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2025.01.440_bib8","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.jacc.2020.09.547","article-title":"Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque","volume":"76","author":"Stone","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.01.440_bib9","first-page":"302","article-title":"Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage: kinetic profile, relationship to interleukin 6 and infarct size","volume":"9","author":"Butt","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jcin.2025.01.440_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.01.440_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0002-9149(90)90079-G","article-title":"Elevation of C-reactive protein in \"active\" coronary artery disease","volume":"65","author":"Berk","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2025.01.440_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1084\/jem.156.1.230","article-title":"Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein","volume":"156","author":"de Beer","year":"1982","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcin.2025.01.440_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/jcp.2006.038729","article-title":"C-reactive protein in vulnerable coronary plaques","volume":"60","author":"Norja","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jcin.2025.01.440_bib14","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/01.ATV.0000081637.36475.BC","article-title":"Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein","volume":"23","author":"Kobayashi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcin.2025.01.440_bib15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10554-019-01758-8","article-title":"Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography: relationship with serum inflammatory marker level","volume":"36","author":"Dai","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jcin.2025.01.440_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d548","article-title":"Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data","volume":"342","author":"C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC)","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jcin.2025.01.440_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jcin.2025.01.440_bib18","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.123.321637","article-title":"Inflammasomes and atherosclerosis: a mixed picture","volume":"132","author":"Tall","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.jcin.2025.01.440_bib19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM200009283431303","article-title":"Multiple complex coronary plaques in patients with acute myocardial infarction","volume":"343","author":"Goldstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2025.01.440_bib20","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0735-1097(01)01135-4","article-title":"Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study","volume":"37","author":"Asakura","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.01.440_bib21","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/01.CIR.0000139858.69915.2E","article-title":"Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients","volume":"110","author":"Hong","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.01.440_bib22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jacc.2008.05.030","article-title":"Frequency and predictor of coronary thin-cap fibroatheroma in patients with acute myocardial infarction and stable angina pectoris a 3-vessel optical coherence tomography study","volume":"52","author":"Fujii","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.01.440_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2016.02.015","article-title":"Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy","volume":"247","author":"Koskinas","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jcin.2025.01.440_bib24","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s12265-022-10250-z","article-title":"The role of the association between serum C-reactive protein levels and coronary plaque macrophage accumulation in predicting clinical events - results from the CLIMA registry","volume":"15","author":"Budassi","year":"2022","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.jcin.2025.01.440_bib25","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(24)00413-6","article-title":"Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT):a multicentre, open-label, randomised controlled trial","volume":"403","author":"Park","year":"2024","journal-title":"Lancet"},{"issue":"10384","key":"10.1016\/j.jcin.2025.01.440_bib26","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jcin.2025.01.440_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.123.066213","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among 13970 contemporary high-risk patients with statin intolerance","volume":"149","author":"Ridker","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.01.440_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvy293","article-title":"Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology","volume":"115","author":"Tunon","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jcin.2025.01.440_bib29","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jcin.2025.01.440_bib30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","article-title":"Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis","volume":"35","author":"Kaptoge","year":"2014","journal-title":"Eur Heart J"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825005151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825005151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:20:35Z","timestamp":1779762035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879825005151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1936879825005151"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2025.01.440","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationships of hsCRP to High-Risk Vulnerable Plaque After NSTEMI","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2025.01.440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}